CNBC

Tempus Founder and CEO, Eric Lefkofsky, discusses how generative AI is more impactful in healthcare diagnostics

Feb 17, 2025
Media Coverage

Related content

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

2026-05-21

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

2026-05-14

Tempus Reports First Quarter 2026 Results

2026-05-05